First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada

3 months ago

Blueprint Mixed Reality Guidance System for shoulder arthroplasty offers surgeons a new tool to execute their pre-operative plan using 3D…

Sona Nanotech Announces Director Retirement

3 months ago

Halifax, Nova Scotia--(Newsfile Corp. - January 10, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")…

St. Pete Medical Group Joins Angel Tree Initiative, Brightening the Holidays for 40 Children and Seniors

3 months ago

St. Pete Medical Group proudly announces its participation in this year's Angel Tree initiative, spreading joy and cheer by supporting…

AMC Health Strengthens Advisory Board with Appointment of Accomplished Business Leader and Payer/Provider Expert Ken Provencher

3 months ago

Provencher brings a broad set of business management, health policy, leadership and experience to AMC Health.NEW YORK, NY / ACCESSWIRE…

Clearwater Medical Group Joins Forces With the Salvation Army Angel Tree Program, Supporting 40 Angels This Holiday Season

3 months ago

CLEARWATER, FL / ACCESSWIRE / January 10, 2024 / Clearwater Medical Group is proud to announce its collaboration with the…

Angle PLC Announces Standard Form for Notification of Major Holdings

3 months ago

GUILDFORD, SURREY / ACCESSWIRE / January 10, 2024 / ANGLE plc:TR-1: Standard form for notification of major holdings:NOTIFICATION OF MAJOR…

CORRECTION BY SOURCE: Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

3 months ago

Correction: The initial release stated Mr. Peter Croden was previously Global President of Upjohn/Pfizer Animal Health Division in Germany. The…

Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance

3 months ago

Collaboration streamlines patient access to oncology clinical trials; further expands Parexel's Site Alliance Network across Asia/PacificDURHAM, N.C. and TOKYO, Jan. 10,…

AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

3 months ago

First enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and…